Martin Pfister
Direktor/Vorstandsmitglied bei WMT AG
Aktive Positionen von Martin Pfister
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Private Equity Investor | 12.05.2011 | - |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | - | - |
WMT AG
WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Martin Pfister
Ehemalige bekannte Positionen von Martin Pfister
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Data Information Intelligence GmbH | Gründer | 01.01.2004 | 31.10.2018 |
Corporate Officer/Principal | 01.01.2004 | 31.10.2018 |
Ausbildung von Martin Pfister
Universität Leipzig | Doctorate Degree |
Statistik
International
Deutschland | 6 |
Operativ
Director/Board Member | 2 |
Private Equity Investor | 1 |
Founder | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |
WMT AG
WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Commercial Services |
Data Information Intelligence GmbH | |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Finance |
- Börse
- Insiders
- Martin Pfister
- Erfahrung